|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $4,169 and $4,296 | |||||||||||||||||
| Assets held for sale | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Other current assets | |||||||||||||||||
| Total Current Assets | |||||||||||||||||
| Property and equipment, net of accumulated depreciation | |||||||||||||||||
| Intangible assets, net of accumulated amortization | |||||||||||||||||
| Deferred costs, net of accumulated amortization | |||||||||||||||||
| Other non-current assets | |||||||||||||||||
| Total Non-Current Assets | |||||||||||||||||
| Total Assets | |||||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||
| Accrued payroll and employee benefits | |||||||||||||||||
| Accrued real estate taxes | |||||||||||||||||
| Total Current Liabilities | |||||||||||||||||
| Long-term debt | |||||||||||||||||
| Other long-term liabilities | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Equity: | |||||||||||||||||
| Preferred Stock, $0.01 par value; 100,000,000 shares authorized and none outstanding as of March 31, 2018 and December 31, 2017 | |||||||||||||||||
| Common Stock, $0.01 par value; 2,000,000,000 shares authorized at March 31, 2018 and December 31, 2017, 132,475,086 shares issued and 117,342,020 shares outstanding as of March 31, 2018 and 132,478,073 shares issued and 117,345,996 shares outstanding as of December 31, 2017 | |||||||||||||||||
| Additional paid-in-capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Treasury stock at cost, 15,133,066 shares at March 31, 2018 and 15,132,077 shares at December 31, 2017 | |||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||
| Noncontrolling interests | |||||||||||||||||
| Total Equity | |||||||||||||||||
| Total Liabilities and Equity | |||||||||||||||||
Loading...
